[HTML][HTML] Breast cancer—epidemiology, risk factors, classification, prognostic markers, and current treatment strategies—an updated review

S Łukasiewicz, M Czeczelewski, A Forma, J Baj… - Cancers, 2021 - mdpi.com
Simple Summary Breast cancer is the most common cancer among women. It is estimated
that 2.3 million new cases of BC are diagnosed globally each year. Based on mRNA gene …

[HTML][HTML] Triple-negative breast cancer: a brief review about epidemiology, risk factors, signaling pathways, treatment and role of artificial intelligence

NM Almansour - Frontiers in Molecular Biosciences, 2022 - frontiersin.org
Triple-negative breast cancer (TNBC) is a kind of breast cancer that lacks estrogen,
progesterone, and human epidermal growth factor receptor 2. This cancer is responsible for …

[HTML][HTML] Vitamin D supplementation and prevention of cardiovascular disease and cancer in the Finnish Vitamin D Trial: a randomized controlled trial

JK Virtanen, T Nurmi, A Aro… - The American journal of …, 2022 - Elsevier
Background Vitamin D insufficiency is associated with risks of cardiovascular diseases
(CVD) and cancer in observational studies, but evidence for benefits with vitamin D …

[HTML][HTML] A narrative review of the evidence for variations in serum 25-hydroxyvitamin D concentration thresholds for optimal health

WB Grant, F Al Anouti, BJ Boucher, E Dursun… - Nutrients, 2022 - mdpi.com
Vitamin D3 has many important health benefits. Unfortunately, these benefits are not widely
known among health care personnel and the general public. As a result, most of the world's …

[HTML][HTML] The role of vitamin D in breast cancer risk and progression

J Vanhevel, L Verlinden, S Doms… - Endocrine-related …, 2022 - erc.bioscientifica.com
The active form of vitamin D 3, 1, 25-dihydroxyvitamin D 3 (1, 25 (OH) 2 D 3), is primarily
known as a key regulator of calcium and phosphate homeostasis. It exerts its biological …

[HTML][HTML] Serum 25-hydroxyvitamin D and cancer risk: a systematic review of Mendelian randomization studies

T Lawler, S Warren Andersen - Nutrients, 2023 - mdpi.com
Epidemiological studies suggest that higher serum 25-hydroxyvitamin D is associated with
lower risk for several cancers, including breast, prostate, colorectal, and lung cancers. To …

[HTML][HTML] Calcifediol (25OH Vitamin D3) Deficiency: A Risk Factor from Early to Old Age

R Bouillon, L Antonio, OR Olarte - Nutrients, 2022 - mdpi.com
Vitamin D deficiency is the main cause of nutritional rickets in children and osteomalacia in
adults. There is consensus that nutritional access to vitamin D can be estimated by …

Circulating vitamin D and breast cancer risk: an international pooling project of 17 cohorts

K Visvanathan, AM Mondul… - European journal of …, 2023 - Springer
Laboratory and animal research support a protective role for vitamin D in breast
carcinogenesis, but epidemiologic studies have been inconclusive. To examine …

EMAS position statement: Vitamin D and menopausal health

P Anagnostis, S Livadas, DG Goulis, S Bretz, I Ceausu… - Maturitas, 2023 - Elsevier
Introduction There is increasing evidence that vitamin D has widespread tissue effects. In
addition to osteoporosis, vitamin D deficiency has been associated with cardiovascular …

[HTML][HTML] Vitamin D intake, serum 25-hydroxyvitamin-D (25 (OH) D) levels, and cancer risk: a comprehensive meta-meta-analysis including meta-analyses of …

ME Arayici, Y Basbinar, H Ellidokuz - Nutrients, 2023 - mdpi.com
It is a well-established fact that inadequate Vitamin D (Vit-D) levels have negative effects on
the development and progression of malignant diseases, particularly cancer. The purpose of …